OCUTX.COM: Keyword Density Checker

Total words: 1856 | 2-word phrases: 473 | 3-word phrases: 526 | 4-word phrases: 552

PAGE INFO

Title	Try to keep the title under 60 characters (72 characters) Ocular Therapeutix: Committed to Safeguarding Vision and Enhancing Lives
Description	Try to keep the meta description between 50 - 160 characters (189 characters) Ocular Therapeutix is a biopharmaceutical company developing transformational treatments that enhance people’s vision and quality of life through consistent and sustainable drug delivery.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	2024 ocular therapeutix	7	1.33%
2	2024 ocular therapeutix™	6	1.14%
3	ocular surface diseases	3	0.57%
4	ocular therapeutix™ to	3	0.57%
5	june 13 2024	3	0.57%
6	presentations sec filings	2	0.38%
7	faqs email alerts	2	0.38%
8	investor faqs email	2	0.38%
9	corporate governance stock	2	0.38%
10	filings corporate governance	2	0.38%
11	sec filings corporate	2	0.38%
12	skip to content	2	0.38%
13	ophthalmic surgery pipeline	2	0.38%
14	team board of	2	0.38%
15	press releases events	2	0.38%
16	overview press releases	2	0.38%
17	may 7 2024	2	0.38%
18	partnership opportunities products	2	0.38%
19	email alerts about	2	0.38%
20	management team board	2	0.38%
21	culture and values	2	0.38%
22	board of directors	2	0.38%
23	present at two	2	0.38%
24	rule 5635c4 may	2	0.38%
25	listing rule 5635c4	2	0.38%
26	nasdaq listing rule	2	0.38%
27	inducement grants under	2	0.38%
28	therapeutix™ to present	2	0.38%
29	to present at	2	0.38%
30	ocular therapeutix™ reports	2	0.38%

#	Keyword	Frequency	Density
1	2024 ocular therapeutix™ to	3	0.54%
2	listing rule 5635c4 may	2	0.36%
3	therapeutix™ to present at	2	0.36%
4	investor faqs email alerts	2	0.36%
5	sec filings corporate governance	2	0.36%
6	presentations sec filings corporate	2	0.36%
7	diseases ophthalmic surgery pipeline	2	0.36%
8	surface diseases ophthalmic surgery	2	0.36%
9	ocular surface diseases ophthalmic	2	0.36%
10	management team board of	2	0.36%
11	team board of directors	2	0.36%
12	board of directors careers	2	0.36%
13	ocular therapeutix™ to host	2	0.36%
14	therapeutix™ to host investor	2	0.36%
15	to host investor day	2	0.36%
16	to present at two	2	0.36%
17	filings corporate governance stock	2	0.36%
18	diversity equityinclusion open positions	2	0.36%
19	faqs email alerts about	2	0.36%
20	nasdaq listing rule 5635c4	2	0.36%
21	may 7 2024 ocular	2	0.36%
22	7 2024 ocular therapeutix	2	0.36%
23	2024 ocular therapeutix™ reports	2	0.36%
24	overview press releases events	2	0.36%
25	june 13 2024 ocular	1	0.18%
26	press releases previous next	1	0.18%
27	dosing study solr in	1	0.18%
28	repeat dosing study solr	1	0.18%
29	releases previous next 0100	1	0.18%
30	plans for repeat dosing	1	0.18%
31	13 2024 ocular therapeutix™	1	0.18%
32	for repeat dosing study	1	0.18%
33	2024 ocular therapeutix™ highlights	1	0.18%
34	and plans for repeat	1	0.18%
35	ocular therapeutix™ highlights exceptional	1	0.18%
36	therapeutix™ highlights exceptional axpaxli™	1	0.18%
37	sol1 enrollment and plans	1	0.18%
38	study solr in wet	1	0.18%
39	enrollment and plans for	1	0.18%
40	48week data from helios	1	0.18%

#	URL	Whois	Check
1	https://dextenza.wistia.com/medias/o3zckepi17	Whois	wistia.com
2	https://dextenza.wistia.com/medias/o3zckepi17	Whois	wistia.com
3	https://www.linkedin.com/company/ocular-therapeutix-inc/	Whois	linkedin.com
4	https://twitter.com/OCUTX	Whois	twitter.com